WEBINAR SESSION TIME

Wednesday, 15th May 2024
18:00 – 18:45pm
CDK 4/6 inhibitors: Addressing
CDK 4/6 inhibitors in HR+ HER2-
ABC Management
Wednesday, 22nd May 2024
18:00 – 18:45pm
Navigation of NSCLC ALK
mutated lung cancer management
Wednesday, 29th May 2024
18:00 – 18:45pm
Therapeutic sequencing in
mRCC: Clinical Characteristics
driving Treatment Choice

SPEAKERS

Wednesday, 15 th May 2024

Wednesday, 22 nd May 2024

Wednesday, 29 th May 2024

Dr Rika Pienaar

Dr Rika Pienaar

Clinical oncologist at Panorama Medi-clinic
in Cape Town

See Bio
Dr Sze Wai Chan

Dr Sze Wai Chan

Director and Head of the Clinical Trial Research Unit
at Sandton Oncology

See Bio
Prof S Mutambirwa

Prof S Mutambirwa

Chairman of The Medical and Scientific
Advisory Board

See Bio

SCHEDULE

Wednesday, 15 th May 2024

Wednesday, 22 nd May 2024

Wednesday, 29 th May 2024

Time
Topic
Speaker
18:00 – 18:05
Welcome and Introductions
Pfizer Medical
18:05 – 18:35
CDK 4/6 inhibitors: Addressing CDK 4/6 inhibitors in
HR+ HER2- ABC Management
Speaker: Dr R Pienaar
18:35 – 18:45
Q&A & Close
Pfizer Medical
Time
Topic
Speaker
18:00 – 18:05
Welcome and Introductions
Pfizer Medical
18:05 – 18:35
Navigation of NSCLC ALK mutated lung cancer
management
Speaker: Dr S Chan
18:35 – 18:45
Q&A & Close
Pfizer Medical
Time
Topic
Speaker
18:00 – 18:05
Welcome and Introductions
Pfizer Medical
18:05 – 18:35
Therapeutic sequencing in mRCC:
Clinical Characteristics driving Treatment Choice
Speaker: Prof S Mutambirwa
18:35 – 18:45
Q&A & Close
Pfizer Medical

The information contained herein is provided for educational purposes only and is not intended to constitute medical advice or replace discussions with a Healthcare Professional.All decisions regarding patient care must be made with a Healthcare Professional, considering the unique characteristics of the patient.

While every effort is made to update the information regularly and to offer the most current, correct and clearly expressed information possible, Pfizer cannot be held responsible for any inaccuracy, errors, omissions or misinterpretations.

Pfizer, its officers and/or its employees do not accept or take any responsibility whatsoever for any loss, whether direct, indirect or consequential, which may arise from reliance on information contained on these pages and actions resulting therefrom.Any liability that would or could arise as a result of the contents of these pages is hereby excluded to the fullest extent allowed by law.

No warranty is given that any files, downloads or applications available via this web site are free of viruses which have the ability to corrupt your system.

Any and all information is subject to change without notice.

The information provided in this site is intended only for appropriate Healthcare Professionals residing in SouthAfrica.